| Literature DB >> 20108533 |
Abstract
A causal link between the increasing environmental pollution and the fast spreading of allergic diseases is currently discussed. The exogenic and endogenic noxious agents contributing to the total environmental load are primarily acting through immunotoxic, sensitizing and neurotoxic mechanisms in animal experiments and in humans. Beside classic allergic-triggering factors (allergen potency, intermittent exposure to different allergen concentrations, presence of microbial bodies and sensitizing phenols), the adjuvant role of environmental pollutants gains increasing importance in allergy induction. Our therapy experience with more than 18.000 atopic eczema patients shows that beside allergic reactions pseudoallergic mechanisms through toxic environmental agents (formaldehyde, industrial and traffic smog, wood preservatives, microbial toxins, additive-rich food, nicotine, alcohol, pesticides, solvents, amalgam-heavy metals) are increasingly incriminated as causal factors for the complex symptomatology. The avoidance and elimination of such triggering factors before and during pregnancy and in early childhood may result in a significant decrease of the incidence of atopic diseases.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20108533 PMCID: PMC5685145
Source DB: PubMed Journal: J Med Life ISSN: 1844-122X
Levels of different organo chlorinated compounds in human fatty tissue [80]
| Year | Number of tests | Average levels (mg/kg) of | ||||||
|---|---|---|---|---|---|---|---|---|
| p,p'- DDE | pp-DDT | Dieldein | HCB | total HCH | PCB | |||
| Belgium | 1975 | 60 | 6.5 | 1.52 | 0.26 | 1.36 | 0.76* | 0.91 |
| Kanada | 1972 | 168 | 2.095 | 0.439 | 0.069 | 0.06 | 0.065 | 0.91 |
| Germany (West) | 282 | 4.4 | 1.1 | 0.14 | 5.6 | 0.99 | 8.3 | |
| Greece | 50 | 7.86 | 1.99 | 0.23 | 3.84 | 0.98** | ||
| Japan | 1974 | 30 | 2.91 | 0.68 | 2.36 | 1.04 | ||
| Northern Ireland | 1975 | 11 | 1.60 | 0.34 | 0.10 | 0.15 | 0.45 | |
| Spain | 1977 | 40 | 2.268 | 1.781 | 0.150 | 0.062 | ||
| Switzerland | 1971/72 | 12 | 3.8 | 1.6 | 0.29 | 1.9 | 0.90 | 1.0 |
| England | 1976/77 | 236 | 5.1 | 0.21 | 0.11 | 0.19 | 0.33 | 0.7 |
| USA | 1973/74 | 898 | 2.1 | 0.15 | 0.21* | |||
| New Zealand | 1973 | 51 | 4.4 | 0.46 | 0.21 | 0.31 | 0.49 | 0.82 |
| Danmark | 1972/73 | 78 | 3.7 | 0.6 | 0.12 | 3.8 | ||
| * Measured as ß-HCH; ** measured as Lindan |
Monoamine and diamine oxidase activities in platelet-rich plasma of atopic eczema patients and healthy controls
| Type B monoamine oxidase (mmol min -1 l -1) | Diamine oxidase (mmol min -1 l -1) | Histamine (ng ml -1) | |
|---|---|---|---|
| Atopic eczema patients | 0.223 ± 0.11 (n = 19) | 0.270 ± 0.089 (n = 18) | 6.63 ± 1.64 (n = 19) |
| Controls | 0.371 ± 0.085 (n = 11) | 0.511 ± 0.125 (n = 10) | 2.15 ± 0.96 (n = 10) |
| Significance Student t test | P < 0.05 | P < 0.001 | P < 0.0001 |
Intestinal microflora of 110 atopic eczema patients and 30 healthy controls
| Lactobacilli | Bifidobacteria | haemolyt. coliforms | Klebsiella | Proteus | pathogenic Clostridia | Candida / Geotrichum | |
| Normal range (germs / g moist stool) | > 10^6 | > 10^8 | < 10^4 | < 10^4 | < 10^4 | < 10^5 | < 10^3 |
| AE-patients n = 110 (p%) | absent or < 10^4 76 (69%) | < 10^7 31 (28.2 %) | > 10^6 52 (47.3%) | > 10^6 36 (32.7 %) | > 10^5 22 (20%) | > 10^6 40 (36.3%) | 10^4-10^7 48 (43.6%) |
| controls n = 30 (p%) | 2 x 10^4 3 (10%) | > 10^8 30 (100%) | 3 x 10^5 2 (6.6%) | < 10^4 30 (100%) | < 10^4 30 (100%) | < 10^5 30 (100%) | 2.5 x 10^4 3 (10 %) |